{"pmid":32321723,"title":"What is the true incidence of COVID-19 in patients with rheumatic diseases?","text":["What is the true incidence of COVID-19 in patients with rheumatic diseases?","Ann Rheum Dis","Favalli, Ennio Giulio","Ingegnoli, Francesca","Cimaz, Rolando","Caporali, Roberto","32321723"],"journal":"Ann Rheum Dis","authors":["Favalli, Ennio Giulio","Ingegnoli, Francesca","Cimaz, Rolando","Caporali, Roberto"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321723","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217615","keywords":["arthritis","biological therapy","hydroxychloroquine"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664895932732276739,"score":8.518259,"similar":[{"pmid":32321722,"title":"To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.","text":["To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.","Ann Rheum Dis","Parperis, Konstantinos","32321722"],"journal":"Ann Rheum Dis","authors":["Parperis, Konstantinos"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321722","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217557","keywords":["arthritis","hydroxychloroquine","lupus erythematosus","rheumatoid","systemic"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664895932632662017,"score":110.429825},{"pmid":32299795,"title":"Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","text":["Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","Ann Rheum Dis","Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas","32299795"],"journal":"Ann Rheum Dis","authors":["Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299795","week":"202016|Apr 13 - Apr 19","doi":"10.1136/annrheumdis-2020-217509","keywords":["antirheumatic agents","autoimmune diseases","biological therapy","communicable diseases, imported","glucocorticoids"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"_version_":1664635401328918528,"score":92.97729},{"pmid":32317316,"title":"Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?","text":["Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?","Ann Rheum Dis","Xie, Wenhui","Wang, Yu","Zhang, Zhuoli","32317316"],"journal":"Ann Rheum Dis","authors":["Xie, Wenhui","Wang, Yu","Zhang, Zhuoli"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317316","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217556","keywords":["autoimmune diseases","hydroxychloroquine","outcome assessment, health care"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Hydroxychloroquine"],"_version_":1664815087775383552,"score":79.67323},{"pmid":32264666,"title":"Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon","text":["Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon","As it is known, we are all in a pandemic situation due to a novel coronavirus, officially named \"Severe Acute Respiratory Syndrome Coronavirus 2\" and the disease caused by the virus named \"Coronavirus disease-2019\". The virus seems to has propensity to infect older male individuals with underlying disease. The clinical features were on a large scale that varies from being an asymptomatic carrier to acute respiratory distress syndrome and multiorgan dysfunction. Fever, dry cough and fatigue are the most common symptoms. Not only, the disease seems to be rare and have a milder course in pediatric age but also respiratory failure, multiorgan dysfunction, and death are extremely rare. Although several comorbidities such as hypertension, diabetes and cardiovascular diseases are defined as a risk factor for developing the acute respiratory syndrome and need for intensive care; immune-compromised situations such as rheumatic disease which require immunosuppressive treatment strikingly are not found to be a risk factor for more severe disease course. However, there is a lack of data regarding the effects of \"Coronavirus disease-2019\" on pediatric patients with rheumatic diseases. Additionally, there are three controversial circumstances that patients with rheumatic diseases are believed to be more likely to have viral infections like \"Severe Acute Respiratory Syndrome Coronavirus 2\", on the other hand, antirheumatic drugs may have a protective and therapeutic role in Coronavirus disease-2019 and children are more unlikely to have serious disease course. Therefore, we aimed to have a contributor role for explaining this conundrum and present a bird's eye view regarding this equivocal issue in this review.","Balkan Med J","Haslak, Fatih","Yildiz, Mehmet","Adrovic, Amra","Barut, Kenan","Kasapcopur, Ozgur","32264666"],"abstract":["As it is known, we are all in a pandemic situation due to a novel coronavirus, officially named \"Severe Acute Respiratory Syndrome Coronavirus 2\" and the disease caused by the virus named \"Coronavirus disease-2019\". The virus seems to has propensity to infect older male individuals with underlying disease. The clinical features were on a large scale that varies from being an asymptomatic carrier to acute respiratory distress syndrome and multiorgan dysfunction. Fever, dry cough and fatigue are the most common symptoms. Not only, the disease seems to be rare and have a milder course in pediatric age but also respiratory failure, multiorgan dysfunction, and death are extremely rare. Although several comorbidities such as hypertension, diabetes and cardiovascular diseases are defined as a risk factor for developing the acute respiratory syndrome and need for intensive care; immune-compromised situations such as rheumatic disease which require immunosuppressive treatment strikingly are not found to be a risk factor for more severe disease course. However, there is a lack of data regarding the effects of \"Coronavirus disease-2019\" on pediatric patients with rheumatic diseases. Additionally, there are three controversial circumstances that patients with rheumatic diseases are believed to be more likely to have viral infections like \"Severe Acute Respiratory Syndrome Coronavirus 2\", on the other hand, antirheumatic drugs may have a protective and therapeutic role in Coronavirus disease-2019 and children are more unlikely to have serious disease course. Therefore, we aimed to have a contributor role for explaining this conundrum and present a bird's eye view regarding this equivocal issue in this review."],"journal":"Balkan Med J","authors":["Haslak, Fatih","Yildiz, Mehmet","Adrovic, Amra","Barut, Kenan","Kasapcopur, Ozgur"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32264666","week":"202015|Apr 06 - Apr 12","doi":"10.4274/balkanmedj.galenos.2020.2020.4.43","keywords":["covid-19","sars virus","hydroxychloroquine","pediatrics","rheumatology","tocilizumab"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664637636055138304,"score":75.39898},{"pmid":32321720,"title":"Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).","text":["Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).","Ann Rheum Dis","Giollo, Alessandro","Adami, Giovanni","Gatti, Davide","Idolazzi, Luca","Rossini, Maurizio","32321720"],"journal":"Ann Rheum Dis","authors":["Giollo, Alessandro","Adami, Giovanni","Gatti, Davide","Idolazzi, Luca","Rossini, Maurizio"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321720","week":"202017|Apr 20 - Apr 26","doi":"10.1136/annrheumdis-2020-217598","keywords":["anti-inflammatory agents, non-steroidal","arthritis, psoriatic","arthritis, rheumatoid","biological therapy","spondylitis, ankylosing"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664895932650487808,"score":74.07282}]}